Fennec CEO’s 13,710‑Share PSU Settlement Signals Strong Insider Confidence for Biotech
Fennec Pharmaceuticals’ CEO settles 13,710 PSUs, boosting insider confidence amid rising stock, strong momentum, and a promising pediatric oncology pipeline.
4 minutes to read